is tirzepatide fsa approved Ivím Health Weight Loss by Patiently |

Eligibility is based on factors like your body mass index, medical history, current medications, and specific goals

Out-of-Pocket Costs Without Coverage If you don't qualify for the GLP-1 Bridge or prefer not to wait until July 2026, here's what you can expect to pay out of pocket in 2026: Approximate Monthly Costs (Without Insurance) Ozempic: ~$199-$499/month through manufacturer savings programs (list price ~$998) Wegovy: ~$149-$199/month through savings programs (list price ~$1,350) Zepbound: ~$349/month through LillyDirect (list price ~$1,060) Mounjaro: ~$349/month through LillyDirect (list price ~$1,060) Freedom and Legacy Advisors St

First, as an alternative for people who can't tolerate side effects, don't want to inject themselves, or can't afford the injectables

After the FDA resolved the tirzepatide shortage in early 2025, the compounding window narrowed but did not vanish